Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs

FEBS Letters

Volumn 560, Issue 1-3, 2004, Pages 210-214

  Hung, Le ^a   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Chloramphenicol acetyltransferase assay; Hepatitis B virus X protein; Hepatocellular carcinoma; RNA interference; Transactivation

Indexed keywords

SMALL INTERFERING RNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN COS1; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B VIRUS; MONKEY; NONHUMAN; ONCOGENE C MYC; OPEN READING FRAME; PRIORITY JOURNAL; TRANSACTIVATION;

HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 1342308035     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(04)00113-9     Document Type: Article

References (57)

1. Bosher J.M., Labouesse M. Nat. Cell Biol. 2:2000;E31-E36.
2. Dykxhoorn D.M., Novina C.D., Sharp P.A. Nat. Rev. Mol. Cell Biol. 4:2003;457-467.
3. Calegari F., Haubensak W., Yang D., Huttner W.B., Buchholz F. Proc. Natl. Acad. Sci. USA. 99:2002;14236-14240.
4. Agrawal N., Dasaradhi P.V., Mohmmed A., Malhotra P., Bhatnagar R.K., Mukherjee S.K. Microbiol. Mol. Biol. Rev. 67:2003;657-685.
5. Martinez J., Patkaniowska A., Urlaub H., Luhrmann R., Tuschl T. Cell. 110:2002;563-574.
6. Ui-Tei K., Zenno S., Miyata Y., Saigo K. FEBS Lett. 479:2000;79-82.
7. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Nature. 411:2001;494-498.
8. Tuchl T. Nat. Biotechnol. 20:2002;446-448.
9. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., Conklin D.S. Genes Dev. 16:2002;948-958.
10. McManus M.T., Sharp P.A. Nat. Rev. Genet. 3:2002;737-747.
11. Maeda I., Kohara Y., Yamamoto M., Sugimoto A. Curr. Biol. 11:2001;171-176.
12. Waterhouse P.M., Helliwell C.A. Nat. Rev. Genet. 4:2000;29-37.
13. Harborth J., Elbashir S.M., Bechert K., Tuschl T., Weber W. J. Cell Sci. 114:2001;4557-4565.
14. Cottrell T.R., Doering T.L. Trends Microbiol. 11:2003;37-43.
15. Gitlin L., Andino R. J. Virol. 77:2003;7159-7165.
16. Caplen N.J. Expert Opin. Biol. Ther. 3:2003;575-586.
17. Li K., Lin S.Y., Brunicardi F.C., Seu P. Cancer Res. 63:2003;3593-3597.
18. Kumar, V., Singh, M., Totey, S.M. and Anand, R.K. (2001) US Patent No. 6,274,788 B1.
19. Lakhtakia R., Kumar V., Reddi H., Mathur M., DattaGupta S., Panda S.K. J. Gastroenterol. Hepatol. 18:2003;80-91.
20. Singh M., Kumar V. Rev. Med. Virol. 13:2003;243-253.
21. Kumar V., Jayasuryan N., Kumar R. Proc. Natl. Acad. Sci. USA. 93:1996;5647-5652.
22. Gorman C.M., Merlino G.T., Willingham M.C., Pastan I., Howard B.H. Proc. Natl. Acad. Sci. USA. 79:1982;6777-6781.
23. Doyle, K. (1996) Protocols and Application Guide, pp. 107-111, Promega Corporation, Madison, WI.
24. Nijhara R., Jana S.S., Goswami S.K., Kumar V., Sarkar D.P. FEBS Lett. 504:2001;59-64.
25. Reddi H., Kumar R., Jain S.K., Kumar V. Virus Genes. 26:2003;227-238.
26. Marcu K.B., Bossone S.A., Patel A.J. Annu. Rev. Biochem. 61:1992;809-860.
27. Sui G., Soohoo C., Affar E.B., Gay F., Shi Y., Forrester W.C., Shi Y. Proc. Natl. Acad. Sci. USA. 99:2002;5515-5520.
28. Kurreck J. Eur. J. Biochem. 270:2003;1628-1644.
29. Lewin A.S., Hauswirth W.W. Trends Mol. Med. 7:2001;221-228.
30. Hasuwa H., Kaseda K., Einarsdottir T., Okabe M. FEBS Lett. 532:2002;227-230.
31. Miyagishi M., Hayashi M., Taira K. Antisense Nucleic Acid Drug Dev. 13:2003;1-7.
32. Grunweller A., Wyszko E., Bieber B., Jahnel R., Erdmann V.A., Kurreck J. Nucleic Acids Res. 31:2003;3185-3193.
33. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., Malvy C. Biochem. Biophys. Res. Commun. 296:2002;1000-1004.
34. Jacque J.M., Triques K., Stevenson M. Nature. 418:2002;435-438.
35. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. Nat. Med. 8:2002;681-686.
36. Qin X.F., An D.S., Chen I.S.Y., Baltimore D. Proc. Natl. Acad. Sci. USA. 100:2002;183-188.
37. Shlomai A., Shaul Y. Hepatology. 37:2003;764-770.
38. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., Kay M.A. Nat. Biotechnol. 21:2003;639-644.
39. Randall G., Grakoui A., Rice C.M. Proc. Natl. Acad. Sci. USA. 100:2003;235-240.
40. Kapadia S.B., Brideau-Anderson A., Chisari F.V. Proc. Natl. Acad. Sci USA. 100:2003;2014-2018.
41. Gitlin L., Karelsky S., Andino R. Nature. 418:2002;430-434.
42. Dector M.A., Romero P., Lopez S., Arias C.F. EMBO Rep. 3:2002;1-6.
43. Jiang M., Milner J. Oncogene. 21:2002;6041-6048.
44. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., Bushman F.D. Curr. Biol. 12:2002;1301-1311.
45. Jia Q., Sun R. J. Virol. 77:2003;3301-3306.
46. Wang Z., Englund P.T. EMBO J. 20:2002;4674-4682.
47. McRobert L., McConkey G.A. Mol. Biochem. Parasitol. 119:2002;273-278.
48. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., Lieberman J. Nat. Med. 9:2003;347-351.
49. Daude N., Marella M., Chabry J. J. Cell Sci. 116:2003;2775-2779.
50. Dang C.V. Mol. Cell. Biol. 19:1999;1-11.
51. Xu Z., Yen T.S., Wu L., Madden C.R., Tan W., Slagle B.L., Ou J.H. J. Virol. 76:2002;2579-2584.
52. Cromlish J.A. Trends Microbiol. 4:1996;270-274.
53. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., Linsley P.S. Nat. Biotechnol. 21:2003;635-637.
54. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D.N., Fesik S.W. Proc. Natl. Acad. Sci USA. 100:2003;6347-6352.
55. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., Iggo R. Nat. Genet. 34:2003;263-264.
56. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R. Nat. Cell Biol. 5:2003;834-839.
57. Peng S.Y., Lai P.I., Hsu H.C. J. Formosa Med. Assoc. 92:1993;866-870.